Aarti Drugs Balance Sheet Health
Financial Health criteria checks 5/6
Aarti Drugs has a total shareholder equity of ₹12.8B and total debt of ₹5.9B, which brings its debt-to-equity ratio to 46%. Its total assets and total liabilities are ₹24.3B and ₹11.5B respectively. Aarti Drugs's EBIT is ₹2.4B making its interest coverage ratio 7.4. It has cash and short-term investments of ₹295.6M.
Key information
46.0%
Debt to equity ratio
₹5.88b
Debt
| Interest coverage ratio | 7.4x |
| Cash | ₹295.60m |
| Equity | ₹12.78b |
| Total liabilities | ₹11.52b |
| Total assets | ₹24.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524348's short term assets (₹12.6B) exceed its short term liabilities (₹7.8B).
Long Term Liabilities: 524348's short term assets (₹12.6B) exceed its long term liabilities (₹3.7B).
Debt to Equity History and Analysis
Debt Level: 524348's net debt to equity ratio (43.7%) is considered high.
Reducing Debt: 524348's debt to equity ratio has reduced from 77% to 46% over the past 5 years.
Debt Coverage: 524348's debt is well covered by operating cash flow (52.4%).
Interest Coverage: 524348's interest payments on its debt are well covered by EBIT (7.4x coverage).